Concepedia

Lingzhi Wu

LW

Statistics

Publications

29

Citations

1.1K

H-Index

19

Active since

2007

Affiliations

Imperial College London(Current)

Chelsea and Westminster Hospital

Zhengzhou University

Tsinghua University

First Affiliated Hospital Zhejiang University

Lingzhi Wu is an author at Imperial College London specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2007–2024

29

Publications

29

Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis

Yibing Sun, Hailin Zhao, Dong-Liang Mu et al. · Cell Death and Disease · 2019 · 166 citations · Full text

, , +17

TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis

Dong Huang, Bolin Xu, Lu Liu et al. · Cell Metabolism · 2021 · 160 citations · Full text

, , +9

PI3K/Akt pathway-mediated HO-1 induction regulates mitochondrial quality control and attenuates endotoxin-induced acute lung injury

Jia Shi, Jianbo Yu, Yuan Zhang et al. · Laboratory Investigation · 2019 · 159 citations · Full text

, , +17

Midazolam and Dexmedetomidine Affect Neuroglioma and Lung Carcinoma Cell Biology In Vitro and In Vivo

Chunyan Wang, Tanweer Datoo, Hailin Zhao et al. · Anesthesiology · 2018 · 91 citations · Full text

, , +17

Macrophage iron dyshomeostasis promotes aging‐related renal fibrosis

Lingzhi Wu, Hongchun Lin, Shaomin Li et al. · Aging Cell · 2024 · 44 citations · Full text

, , +17

1–5 of 29